<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01587508</url>
  </required_header>
  <id_info>
    <org_study_id>EF 127</org_study_id>
    <nct_id>NCT01587508</nct_id>
  </id_info>
  <brief_title>Study Comparing A New Drug Containing The Combination Meloxicam And Cyclobenzaprine In The Treatment Of Acute Lumbago</brief_title>
  <official_title>A Phase III, Randomized, Single-Blind, Superiority Study Comparing The Efficacy And Tolerability Of A New Drug Containing The Combination Meloxicam And Cyclobenzaprine And The Same Components Alone In The Treatment Of Acute Lumbago</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Eurofarma Laboratorios S.A.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Eurofarma Laboratorios S.A.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess the efficacy end tolerability of a new drug containing
      the combination meloxicam and cyclobenzaprine (7,5/10mg) and the same components alone in the
      treatment of acute lumbago.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To assess the efficacy and tolerability of a new drug containing the combination meloxicam
      and cyclobenzaprine in the treatment of acute lumbago, compared to the same components alone.

      Some eligibility criteria:

      Have a normal X-ray of the lumbar spine for the age; Have a baseline score in the VAS higher
      than or equal to 40 mm
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    The comparator product was withdrawn from the brazilian market not being possible to conduct
    the design regarding initially planned.
  </why_stopped>
  <start_date>May 2013</start_date>
  <completion_date type="Actual">May 2013</completion_date>
  <primary_completion_date type="Actual">May 2013</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain Reduction</measure>
    <time_frame>Pain reduction 3 days after the administration of study drugs</time_frame>
    <description>Compare the treatment groups for the efficacy in pain reduction, 3 days after the administration of study drugs, when compared to the baseline assessment.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Frequency of rescue medication use</measure>
    <time_frame>During study treatment, an expected average of 7days</time_frame>
    <description>Assessment of frequency of rescue medication use, as well as the proportion of patients during study treatment;</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Acute Lumbago</condition>
  <arm_group>
    <arm_group_label>meloxicam - Movatec®</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>cyclobenzaprine - Miosan®,</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>meloxicam/cyclobenzaprine hydrochloride</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>meloxicam/cyclobenzaprine hydrochloride</intervention_name>
    <description>two oral capsules a day during approximately 07 days</description>
    <arm_group_label>meloxicam/cyclobenzaprine hydrochloride</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>meloxicam - Movatec®</intervention_name>
    <description>two oral tablet a day during approximately 07 days</description>
    <arm_group_label>meloxicam - Movatec®</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>cyclobenzaprine - Miosan®</intervention_name>
    <description>two oral tablet a day during approximately 07 days</description>
    <arm_group_label>cyclobenzaprine - Miosan®,</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Sign, initial and date the Informed Consent Form (ICF);

          -  Be between 18 and 75 years old;

          -  Have acute lumbago with onset in less than 72 hours;

          -  Have a normal X-ray;

          -  Have a baseline score in the VAS higher than or equal to 40 mm;

        Exclusion Criteria:

          -  Use of triptans;

          -  Use of monoamine oxidase inhibitors;

          -  Use of NSAIDs within the last week;

          -  Previous use of narcotics;

          -  Have any rheumatologic disease;

          -  Conditions of chronic pain;

          -  Have any significant chronic comorbidity;

          -  Previous history of gastrointestinal bleed or ulcers;

          -  History of allergy to any of the components of study medications;

          -  Recent history of a myocardial infarction, cardiac arrhythmia, cardiac conduction
             block or change, or congestive heart failure;

          -  Female patients who are pregnant or breastfeeding or who wish to become pregnant or
             who deny using safe contraceptive methods during the study will not be enrolled in the
             study;

          -  Have participated in another clinical trial within the last 12 months.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alceu Chueiri</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital de Base de São José do Rio Preto</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Paulo Guilherme</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Santa Marcelina</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Wagner Caiafa</last_name>
    <role>Principal Investigator</role>
    <affiliation>Santa Casa de Juiz de Fora</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Antonio Scotton</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centro MIneiro de Pesquisa - Juiz de Fora</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Lindomar G. Oliveira</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clínica de Ortopedia e Fraturas de Goiania</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Antonio Carlos Ximenes</last_name>
    <role>Principal Investigator</role>
    <affiliation>CIP Pesquisas Médicas Ltda</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sonia Alvarenga</last_name>
    <role>Principal Investigator</role>
    <affiliation>Faculdade de Medicina ABC</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Gilberto Brandão</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clínica Perdizes</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Luciana Teixeira</last_name>
    <role>Principal Investigator</role>
    <affiliation>IMA Brasil - Instituto de Medicina Avançada</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Antonio Tarcísio</last_name>
    <role>Principal Investigator</role>
    <affiliation>Santa Casa de Misericórdia de Belo Horizonte</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Carlos Roberto Galia</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital de Clínicas de Porto Alegre</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mauro Hernandes</last_name>
    <role>Principal Investigator</role>
    <affiliation>Santa Casa de Votuporanga</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Clínica de Ortopedia e Fraturas de Goiânia</name>
      <address>
        <city>Goiania</city>
        <state>GO</state>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CIP Pesquisas Médicas Ltda</name>
      <address>
        <city>Goiânia -</city>
        <state>GO</state>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Santa Casa de Misericórdia de Belo Horizonte</name>
      <address>
        <city>Belo Horizonte</city>
        <state>MG</state>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Santa Casa de Juíz de Fora</name>
      <address>
        <city>Juiz de Fora</city>
        <state>MG</state>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital de Clínicas de Porto Alegre</name>
      <address>
        <city>Porto Alegre</city>
        <state>RS</state>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Faculdade de Medicina ABC</name>
      <address>
        <city>Santo Andre,</city>
        <state>SP</state>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinica de Ortopedia e Fisiatria Perdizes</name>
      <address>
        <city>São Paulo</city>
        <state>SP</state>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Santa Marcelina</name>
      <address>
        <city>São Paulo</city>
        <state>SP</state>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>IMA Brasil</name>
      <address>
        <city>São Paulo</city>
        <state>SP</state>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Santa Casa de Votuporanga</name>
      <address>
        <city>Votuporanga</city>
        <state>SP</state>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospítal de Base</name>
      <address>
        <city>São José Rio Preto</city>
        <state>São Paulo</state>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>April 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 24, 2012</study_first_submitted>
  <study_first_submitted_qc>April 26, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 30, 2012</study_first_posted>
  <last_update_submitted>April 29, 2016</last_update_submitted>
  <last_update_submitted_qc>April 29, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 3, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Low Back Pain</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Meloxicam</mesh_term>
    <mesh_term>Amitriptyline</mesh_term>
    <mesh_term>Cyclobenzaprine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

